|
|
Volumn 49, Issue 5, 2002, Pages 827-830
|
|
The successful introduction of a programme to reduce the use of iv ciprofloxacin in hospital
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
CARBAPENEM DERIVATIVE;
CEFTAZIDIME;
CIPROFLOXACIN;
PIPERACILLIN;
TAZOBACTAM;
ANTIINFECTIVE AGENT;
ARTICLE;
CONTROLLED STUDY;
COST CONTROL;
DRUG COST;
DRUG INDICATION;
DRUG USE;
HOSPITAL PURCHASING;
HUMAN;
INTENSIVE CARE UNIT;
MEDICAL STAFF;
PATIENT EDUCATION;
PRESCRIPTION;
UNITED KINGDOM;
WARD;
DRUG UTILIZATION;
ECONOMICS;
HOSPITAL PHARMACY;
INTRAVENOUS DRUG ADMINISTRATION;
ORGANIZATION AND MANAGEMENT;
PHARMACY AND THERAPEUTICS COMMITTEE;
ANTI-INFECTIVE AGENTS;
CIPROFLOXACIN;
COST SAVINGS;
DRUG UTILIZATION;
GREAT BRITAIN;
INJECTIONS, INTRAVENOUS;
PHARMACY AND THERAPEUTICS COMMITTEE;
PHARMACY SERVICE, HOSPITAL;
|
|
EID: 0036001184
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: 10.1093/jac/dkf003 Document Type: Article |
|
Times cited : (2)
|
|
References (8)
|
